AMZN
Amazon.com, Inc.
AMZN has the edge over MLR overall, supported by stronger valuation and stronger fundamentals.
MLR
Miller Industries, Inc.
MLR offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
MLR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Strong | |
| Strong |
MLR's cash flow and balance sheet are currently strong, and its revenue and profitability are stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over MLR in the historical PE scenario, which offers more potential upside but is not a forecast.
MLR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.6x | $14.45 | -70% |
| Fair | 14x | $20.88 | -57% |
| Forward | 17x | $48.71 | — |
| Expensive | 21x | $31.75 | -35% |
| Current | 32x | $48.71 | — |
Historical ranges are pointers, not guarantees.
MLR's PE is in its expensive range at 32x. If earnings grow as analysts expect, today's price would be 17x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
MLR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| High |
MLR has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over MLR on earnings, with more consistent year-over-year improvement.
MLR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.85 | +90% |
| Q3 2026 | $1.50 | -42% |
| Q2 2026 | $1.24 | -66% |
| Q1 2026 | $1.34 | -71% |
| Q4 2025 | $1.98 | -64% |
| Q3 2025 | $2.58 | -57% |
| Q2 2025 | $3.64 | -41% |
| Q1 2025 | $4.69 | -18% |
| Q4 2024 | $5.47 | +7.9% |
MLR's earnings per share have fallen from their peak: $1.50 over the past year, against $6.22 in mid-2024.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over MLR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over MLR on profitability, with a higher operating margin.
MLR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $212.2M | +19% |
| Q2 2026 | $240M | +12% |
| Q1 2026 | $180.9M | -20% |
| Q4 2025 | $171.9M | -23% |
| Q3 2025 | $178.7M | -43% |
| Q2 2025 | $214M | -42% |
| Q1 2025 | $225.7M | -36% |
| Q4 2024 | $221.9M | -25% |
MLR's revenue is recovering but still below its 2024 peak: $212M last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +1.1 points |
| Q2 2026 | 4.2% | -1.1 points |
| Q1 2026 | 0.9% | -3.9 points |
| Q4 2025 | 2.9% | -2.8 points |
| Q3 2025 | 2.4% | -3.9 points |
| Q2 2025 | 5.3% | -1.8 points |
| Q1 2025 | 4.8% | -1.4 points |
| Q4 2024 | 5.7% | -1.4 points |
MLR's operating margin was 3.5% last quarter, up 1.1 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
MLR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $13.7M | -25% |
| Q2 2026 | $28M | +9.7% |
| Q1 2026 | $22.8M | +$25.2M |
| Q4 2025 | $43.8M | +$56.7M |
| Q3 2025 | $18.1M | -25% |
| Q2 2025 | $25.6M | +$39.4M |
| Q1 2025 | -$2.4M | -156% |
| Q4 2024 | -$13M | -396% |
MLR has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
MLR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -36.5K shares |
| 1 year | -0.9% | -110K shares |
| 3 years | -0.3% | -30K shares |
| 5 years | +0.6% | +74K shares |
| Available history | +0.7% | +85K shares |
MLR has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.7M |
| Q2 2026 | $2.5M |
| Q1 2026 | $2.2M |
| Q4 2025 | $2.2M |
| Q3 2025 | $1.2M |
| Q2 2025 | $500,000 |
| Q1 2025 | $2.1M |
| Q4 2024 | — |
MLR spent $10M buying back its own shares over the past year, up 155% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
MLR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.4x | Net Cash |
| Q2 2026 | -1.4x | Net Cash |
| Q1 2026 | -0.8x | Net Cash |
| Q4 2025 | -0.3x | Net Cash |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 0.4x | Very low |
MLR has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
MLR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 20.2 | Neutral |
MLR's weekly RSI is 45 (neutral) and its Stochastic is 20 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over MLR on valuation relative to its sector.
MLR PE vs Consumer Cyclical Sector
| Metric | MLR | Sector median | Relative |
|---|---|---|---|
| PE | 32x | 18x | 80% above |
| PE % | 93 | 47 | 46 pts above |
MLR is trading at 32x earnings, a 80% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over MLR on trend strength, trading above more of its moving averages.
MLR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $51.2 | 4.9% below |
| 20 week MA | $52.5 | 7.1% below |
| 50 week MA | $47.6 | 2.4% above |
| 100 week MA | $47.3 | 3% above |
| 200 week MA | $46.8 | 4.2% above |
MLR has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 4.2% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
MLR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.2 | $36.8 | -1% |
| 2021 | $36.8 | $32.5 | -12% |
| 2022 | $32.5 | $26.4 | -19% |
| 2023 | $26.4 | $42.3 | +60% |
| 2024 | $42.3 | $65.7 | +55% |
| 2025 | $65.7 | $38.2 | -42% |
| 2026 YTD | $38.2 | $48.7 | +28% |
MLR has the edge over AMZN on returns for 2026, with the stronger performance.